MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05100cam a2200697 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn952337016 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220712033906.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160125s2016 nyua ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2020678064 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
YDXCP |
| -- |
N$T |
| -- |
OCLCF |
| -- |
SNK |
| -- |
DKU |
| -- |
AUW |
| -- |
IGB |
| -- |
D6H |
| -- |
VTS |
| -- |
AGLDB |
| -- |
AU@ |
| -- |
G3B |
| -- |
S8J |
| -- |
S9I |
| -- |
STF |
| -- |
VLY |
| -- |
OCLCO |
| -- |
OCLCA |
| -- |
OCLCO |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781634847247 |
| Qualifying information |
ebook |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1634847245 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
163484713X |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781634847131 |
| 029 1# - (OCLC) |
|---|
| OCLC library identifier |
AU@ |
| System control number |
000060915841 |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)952337016 |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC280.B48 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WI 765 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
HEA |
| Subject category code subdivision |
039000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
014000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
022000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
112000 |
| Source |
bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
045000 |
| Source |
bisacsh |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.99/436 |
| Edition number |
23 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Bile duct cancer : |
| Remainder of title |
symptoms, treatment, and prognosis / |
| Statement of responsibility, etc |
Donna E. Matthews, editor. |
| 264 #1 - |
|---|
| -- |
New York : |
| -- |
Nova Biomedical, |
| -- |
[2016] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. |
| 336 ## - |
|---|
| -- |
text |
| -- |
txt |
| -- |
rdacontent |
| 337 ## - |
|---|
| -- |
computer |
| -- |
c |
| -- |
rdamedia |
| 338 ## - |
|---|
| -- |
online resource |
| -- |
cr |
| -- |
rdacarrier |
| 347 ## - |
|---|
| -- |
data file |
| -- |
rda |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
cancer etiology, diagnosis and treatments |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 588 ## - |
|---|
| -- |
Description based on print version record. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
BILE DUCT CANCER SYMPTOMS, TREATMENT AND PROGNOSIS ; BILE DUCT CANCER SYMPTOMS, TREATMENT AND PROGNOSIS ; CONTENTS ; PREFACE; Chapter 1 CHOLANGIOCARCINOMA: SYMPTOMS AND CURRENT STATE OF MEDICAL AND SURGICAL MANAGEMENT ; ABSTRACT; INTRODUCTION; SYMPTOMS ; TREATMENT; INTRAHEPATIC CHOLANGIOCARCINOMA ; HILAR CHOLANGIOCARCINOMA AND EXTRAHEPATIC CHOLANGIOCARCINOMA ; PROGNOSIS ; REFERENCES ; Chapter 2 EXTRA HEPATIC CHOLANGIOCARCINOMA: SYMPTOMS, TREATMENT AND PROGNOSIS ; ABSTRACT ; EPIDEMIOLOGY ; RISK FACTORS ; CLINICAL PRESENTATION ; DIAGNOSTIC WORK-UP ; ANATOMY |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
LABORATORY INVESTIGATIONS IMAGING ; Ultrasound (US) ; Computed Tomography (CT)/Multi-Detector Computed Tomography (MDCT) ; Magnetic Resonance Imaging (MRI) ; Endoscopic Retrograde Cholangiopancreatography (ERCP)/Percutaneous Transhepatic Cholangiography (PTC) ; Endoscopic Ultrasonography (EUS)/Intraductal Ultrasonography (IDUS) ; Positron Emission Tomography (PET) ; Biopsy ; Staging ; Treatment; Distal Cholangiocarcinoma ; Perihilar Cholangiocarcinoma ; Preoperative Liver Evaluation/Interventions ; TREATMENT OF BILIARY OBSTRUCTION ; Adjuvant Therapies |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Neoadjuvant Therapy and Transplantation Palliative Treatment ; REFERENCES ; Chapter 3 PREVALENCE OF BILE DUCT CANCER AS MEASURED BY DISCHARGES FROM DIAGNOSIS-PROCEDURE-COMBINATION (DPC) PARTICIPATING HOSPITALS AMONG BENEFICIARIES OF A PRINTING INDUSTRY HEALTH INSURANCE SOCIETY IN COMPARISON WITH GENERAL POPULATION ; ABSTRACT ; INTRODUCTION ; SUBJECTS AND METHODS ; 1. DPC Data from General Population ; 2. DPC data from HISPI; 3. Analysis ; 4. Ethical Approval ; RESULTS ; DISCUSSION ; ACKNOWLEDGMENTS ; REFERENCES ; Chapter 4 MEDICAL TREATMENT OF ADVANCED BILIARY TRACT CANCER ; ABSTRACT |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1.1. INTRODUCTION 1.2. CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER ; 1.2.1. Combinations of Gemcitabine and Platinum Derivatives ; 1.2.2. Combinations of Gemcitabine and Fluoropyrimidines ; 1.2.3. Triple-Drug Chemotherapy Regimens; 1.2.4. S-1 Based Combinations ; 1.2.5. Second-Line Chemotherapy ; 1.3 TARGETED THERAPIES IN ADVANCED BILIARY DUCT CANCER ; 1.3.1. Therapies Targeting EGFR Pathway ; 1.3.1.1. Erlotinib; 1.3.1.2. Cetuximab ; 1.3.1.3. Panitumumab; 1.3.1.4. Afatinib ; 1.3.2. Therapies Targeting the VEGF Pathway ; 1.3.2.1. Bevacizumab ; 1.3.2.2. Sunitinib ; 1.3.2.3. Cediranib |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
1.3.2.4. Sorafenib1.4. IMMUNOTHERAPY IN BILIARY TRACT CANCER ; 1.4.1. Tumor-Associated-Antigens ; 1.4.2. Checkpoint Inhibitors ; 1.4.3. How Can We Explain an Enhanced Immune Response in Biliary Cancers? ; CONCLUSION ; REFERENCES ; BIOGRAPHICAL SKETCH ; INDEX |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
eBooks on EBSCOhost |
| Provenance (VM) [OBSOLETE] |
EBSCO eBook Subscription Academic Collection - Worldwide |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Bile ducts |
| General subdivision |
Cancer. |
| 9 (RLIN) |
1115952 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Bile Duct Neoplasms |
| 9 (RLIN) |
1115953 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
HEALTH & FITNESS / Diseases / General |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
92207 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL / Clinical Medicine |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
92208 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL / Diseases |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
92209 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL / Evidence-Based Medicine |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
92210 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
MEDICAL / Internal Medicine |
| Source of heading or term |
bisacsh |
| 9 (RLIN) |
92211 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Bile ducts |
| General subdivision |
Cancer. |
| Source of heading or term |
fast |
| -- |
(OCoLC)fst00831700 |
| 9 (RLIN) |
1115952 |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Matthews, Donna E., |
| Relator term |
editor. |
| 9 (RLIN) |
1115954 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Print version: |
| Title |
Bile duct cancer |
| Place, publisher, and date of publication |
New York : Nova Biomedical, [2016] |
| International Standard Book Number |
9781634847131 |
| Record control number |
(DLC) 2016931579 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Cancer etiology, diagnosis, and treatments. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1258682">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1258682</a> |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
13048988 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
1258682 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
INOPJ |
